- Trial for new heart failure drug LCZ696 is stopped early due to overwhelmingly beneficial results - will move forward for FDA approval by end of this year. http://www.nejm.org/doi/full/10.1056/nejmoa1409077 236 comments science
Linking pages
- Absolute Risk Reduction: Your Secret Weapon in Literature Evaluation — tl;dr pharmacy https://www.tldrpharmacy.com/content/absolute-risk-reduction 0 comments
- New Novartis Drug Effective in Treating Heart Failure - The New York Times http://www.nytimes.com/2014/08/31/business/new-novartis-drug-shows-striking-efficacy-in-treating-heart-failure.html 0 comments
Linked pages
Related searches:
Search whole site: site:www.nejm.org
Search title: Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM
See how to search.